Effects and interactions in an environmentally relevant mixture of pharmaceuticals.
about
Human health risk assessment of pharmaceuticals in water: issues and challenges aheadHidden drivers of low-dose pharmaceutical pollutant mixtures revealed by the novel GSA-QHTS screening methodPharmaceuticals and personal care products in waters: occurrence, toxicity, and risk.An update on the strategies in multicomponent activity monitoring within the phytopharmaceutical fieldReview of the occurrence of anti-infectives in contaminated wastewaters and natural and drinking waters.Capability of the natural microbial community in a river water ecosystem to degrade the drug naproxen.Water-borne pharmaceuticals reduce phenotypic diversity and response capacity of natural phytoplankton communities.Consumer-perceived risks and choices about pharmaceuticals in the environment: a cross-sectional study.Practice, awareness and opinion of pharmacists toward disposal of unwanted medications in KuwaitOccurrence of Emerging Micropollutants in Water Systems in Gauteng, Mpumalanga, and North West Provinces, South Africa.Potential environmental implications of nano-enabled medical applications: critical review.Do pharmaceuticals reach and affect the aquatic ecosystems in Brazil? A critical review of current studies in a developing country.Chronic and low exposure to a pharmaceutical cocktail induces mitochondrial dysfunction in liver and hyperglycemia: Differential responses between lean and obese mice.Toxicity of individual pharmaceuticals and their mixtures to Aliivibrio fischeri: Experimental results for single compounds and considerations of their mechanisms of action and potential acute effects on aquatic organisms.Development of a UPLC-MS/MS method for the determination of ten anticancer drugs in hospital and urban wastewaters, and its application for the screening of human metabolites assisted by information-dependent acquisition tool (IDA) in sewage samplesToxicity of the mixture of selected antineoplastic drugs against aquatic primary producers.Occurrence of diazepam and its metabolites in wastewater and surface waters in Beijing.Occurrence of endocrine disrupters and selected pharmaceuticals in Aisonas River (Greece) and environmental risk assessment using hazard indexes.Industrial-scale application of the plunger flow electro-oxidation reactor in wastewater depth treatment.Advanced treatment of municipal secondary effluent by catalytic ozonation using Fe3O4-CeO2/MWCNTs as efficient catalyst.Stability of lysosomal membrane in Carcinus maenas acts as a biomarker of exposure to pharmaceuticals.Ecotoxicological risk assessment of chosen pharmaceuticals detected in surface waters.Nitrate and carbon matter removals from real effluents using Si/BDD electrode.Acute effects of various antibiotic combinations on acetoclastic methanogenic activity.Seasonal occurrence, removal and risk assessment of 10 pharmaceuticals in 2 sewage treatment plants of Guangdong, China.UPLC-MS/MS analysis of antibiotics in pharmaceutical effluent in Tunisia: ecotoxicological impact and multi-resistant bacteria dissemination.Pharmaceuticals in the environment: an educational perspective.Fate of selected drugs in the wastewater treatment plants (WWTPs) for domestic sewage.Biological Removal of the Mixed Pharmaceuticals: Diclofenac, Ibuprofen, and Sulfamethoxazole Using a Bacterial Consortium.Risk assessment of environmental mixture effectsResilience to heat waves in the aquatic snail Lymnaea stagnalis : Additive and interactive effects with micropollutantsAntibiotics as CECs: An Overview of the Hazards Posed by Antibiotics and Antibiotic Resistance
P2860
Q24631727-B73562A9-56BC-4685-BC36-2AFEC6F8D36CQ28831097-19BE1C45-7341-4DB9-B267-7E04EEC55F37Q33764240-E1A9EA1B-15AD-4BAA-B6E6-4847664DADBBQ34195271-F28A4BD1-A8BD-44ED-BEC0-22E88F1FA7DDQ34983685-C9E72903-E191-4851-B738-C5529A138105Q35204855-9C0F7B41-9B56-4B9D-BD56-EAF42922D68DQ36318178-322E7C05-BB3F-4FA7-84DD-07552EC27C63Q36922660-61DFE2D1-FF29-4AAA-85E9-96FB0DF6C40DQ37098784-385F1512-AEF2-49A6-87F4-DC0A8F9A6E2CQ37628830-602089D0-D92B-4C78-8857-89BE291E0E4BQ38193126-838DAADB-2318-4F2A-9B3E-59AAE2251119Q38979288-45249F97-AC9B-4225-BA31-87DDBC49FBD1Q39512563-05EE5D6C-1CAB-44D5-ABB6-BA21F6DB21BCQ39551141-B01A36BA-858A-46EF-BBB1-F8B493FC8FB0Q40095970-48B30802-66A2-4360-BF2C-039A5077507AQ40119818-2D02C3DD-834F-4AC0-AAED-E40A8EC1089BQ40199955-7DC1556B-A476-4461-8E02-7200BC27FD87Q43337009-550899C0-784B-4A5E-9645-C3959BF072D6Q43350313-9B61BE59-24EC-4D69-8865-863A02397382Q43360123-73B9E560-CCBE-4AAA-9ACC-FC859009AD1FQ43685827-34C63500-D59E-459D-B2B5-6002C40C8672Q46300466-A981714E-5F7E-49B3-B43F-29934C0E9641Q46306825-4EBE800F-BC79-44B1-8097-3A80604C31B9Q46812843-245F5594-3B90-4410-8E40-2B6C13004EA3Q47410334-BD9173FE-C011-487C-8638-518F47AA2540Q47759467-00A411CB-6F74-41DD-97A5-FD6F228EEDFAQ48539174-63F0486B-D95D-4F00-9714-62A2A16871E2Q50858244-FD034AFB-0D93-4DD0-ADBD-59D507844A14Q55266583-BFAB0D1D-5BE8-402E-9D9C-093A6CA48666Q57157856-906A61A9-7FAB-4DC5-8D26-9B6378FDF64BQ57238659-2547E15E-FA2F-480B-8857-8632597E3F71Q57900442-B665C8A0-ED4F-4B40-8A59-42E14C08CC82
P2860
Effects and interactions in an environmentally relevant mixture of pharmaceuticals.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Effects and interactions in an environmentally relevant mixture of pharmaceuticals.
@en
type
label
Effects and interactions in an environmentally relevant mixture of pharmaceuticals.
@en
prefLabel
Effects and interactions in an environmentally relevant mixture of pharmaceuticals.
@en
P2093
P2860
P356
P1476
Effects and interactions in an environmentally relevant mixture of pharmaceuticals.
@en
P2093
Chiara Orlandi
Ettore Zuccato
Francesco Pomati
Moira Clerici
P2860
P304
P356
10.1093/TOXSCI/KFM291
P577
2007-11-28T00:00:00Z